Asia Pacific Biosimilar Insulin Glargine & Lispro Market Size, Share & Forecast 2025

} ?>
View by Category
About This Presentation
Title:

Asia Pacific Biosimilar Insulin Glargine & Lispro Market Size, Share & Forecast 2025

Description:

Biosimilar is a biological product which is similar to the reference product, already approved by authorities and marketed by companies other than the patent holder company. Insulin is a hormone produced by pancreatic cell which is responsible for absorption of glucose from the blood. Lack of insulin in the body causes diabetes. Insulin is available in different forms depending upon the sources such as animal derived, chemically synthesized or produced through recombinant technology. Insulin can be categorized as fast acting, immediate acting and long acting depending upon the absorption of insulin from the blood in the body. Glargine and lispro are two types of insulin. – PowerPoint PPT presentation

Number of Views:7

less

Write a Comment
User Comments (0)